EraGen to Develop Multiplex MDx Tests on Applied BioCode Platform
April 21, 2011
EraGen to Develop Multiplex MDx Tests on Applied BioCode Platform
Under the agreement, EraGen receives access to Applied BioCode's barcoded magnetic bead technology and CE-Marked BioCode-1000 system, which EraGen will couple with its MultiCode-PLx assays for analyzing nucleic acid targets in infectious disease and genetic testing.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- EraGen Again Moving Multiplex Assays Toward Clinic in Wake of Luminex Separation
May 27, 2010 / PCR Insider - Recent Studies Prop Up Multiplex PCR Testing for Respiratory Viruses
May 26, 2010 / PCR Insider - Luminex in Alpha Stage for New MDx Platform; Ups R&D Spending to Prep for Market
May 2, 2013 / PCR Insider - Luminex Leveraging Advanced Liquid Logic Alliance to Develop Field-based MDx/Immunoassay System
May 16, 2013 / PCR Insider - Luminex, Posting Q1 Revenue Growth, Provides Updates on Gastro Pathogen, NeoPlex Assays
April 30, 2013 / BioArray News